We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.88B
AUM Growth
-$1.57B
Cap. Flow
+$103M
Cap. Flow %
1.15%
Top 10 Hldgs %
15.32%
Holding
763
New
20
Increased
297
Reduced
294
Closed
39

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$28M
2
PRGO icon
Perrigo
PRGO
+$25.4M
3
J icon
Jacobs Solutions
J
+$23.4M
4
ICUI icon
ICU Medical
ICUI
+$21.3M
5
SSB icon
SouthState Bank Corp
SSB
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Healthcare 18.06%
3 Industrials 15.07%
4 Financials 12.92%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFS
301
DELISTED
Discover Financial Services
DFS
$5.3M 0.06%
56,030
+240
+0.4% +$25.7K
RSP icon
302
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$5.29M 0.06%
39,446
-243
-0.6% -$35.6K
RDUS
303
DELISTED
Radius Recycling
RDUS
$5.28M 0.06%
160,913
+2,137
+1% +$91.1K
VCYT icon
304
Veracyte
VCYT
$3.7B
$5.27M 0.06%
264,761
+17,406
+7% +$352K
NDSN icon
305
Nordson
NDSN
$16.6B
$5.26M 0.06%
25,976
-811
-3% -$173K
IWD icon
306
iShares Russell 1000 Value ETF
IWD
$82.2B
$5.16M 0.06%
35,628
-244
-0.7% -$38.2K
PHR icon
307
Phreesia
PHR
$663M
$5.12M 0.06%
204,986
+13,558
+7% +$299K
HWC icon
308
Hancock Whitney
HWC
$6.2B
$5.11M 0.06%
+115,336
New +$5.49M
SGRY icon
309
Surgery Partners
SGRY
$2.01B
$5.09M 0.06%
175,960
+52,351
+42% +$2.29M
PCH
310
DELISTED
PotlatchDeltic
PCH
$5.07M 0.06%
114,820
-1,828
-2% -$94.3K
BAX icon
311
Baxter International
BAX
$13.5B
$5.07M 0.06%
79,114
-4,484
-5% -$325K
IWR icon
312
iShares Russell Mid-Cap ETF
IWR
$56B
$5.06M 0.06%
78,279
+2,245
+3% +$160K
LYB icon
313
LyondellBasell Industries
LYB
$20B
$5.06M 0.06%
57,940
-562
-1% -$58.5K
CIEN icon
314
Ciena
CIEN
$53.4B
$4.95M 0.06%
108,167
+17,085
+19% +$886K
PCRX icon
315
Pacira BioSciences
PCRX
$1.04B
$4.94M 0.06%
84,743
+25,078
+42% +$1.64M
SITM icon
316
SiTime
SITM
$16B
$4.94M 0.06%
30,295
+8,968
+42% +$1.7M
IOSP icon
317
Innospec
IOSP
$2.12B
$4.92M 0.06%
51,417
+14,863
+41% +$1.44M
EVBG
318
DELISTED
Everbridge, Inc. Common Stock
EVBG
$4.92M 0.06%
176,534
+27,214
+18% +$1.1M
ADI icon
319
Analog Devices
ADI
$179B
$4.86M 0.05%
33,302
-2,063
-6% -$325K
ECL icon
320
Ecolab
ECL
$78.1B
$4.84M 0.05%
31,472
-204
-0.6% -$33.8K
FIS icon
321
Fidelity National Information Services
FIS
$23.1B
$4.82M 0.05%
52,452
-3,475
-6% -$345K
ULTA icon
322
Ulta Beauty
ULTA
$22B
$4.82M 0.05%
12,492
-19,911
-61% -$7.91M
CHE icon
323
Chemed
CHE
$7.07B
$4.81M 0.05%
+10,256
New +$5M
AGYS icon
324
Agilysys
AGYS
$2.97B
$4.81M 0.05%
101,696
+12,415
+14% +$484K
XEL icon
325
Xcel Energy
XEL
$48.8B
$4.77M 0.05%
67,336
+98
+0.1% +$7.13K

Similar funds

Segall Bryant & Hamill's Q2 2022 Portfolio in Review

As of Q2 2022, Segall Bryant & Hamill held 763 positions worth $8.88B, down 15% from $10.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2022 filing shows 20 new, 297 increased, 294 reduced and 39 closed positions. Its largest new stake was Perrigo: 684,450 shares worth $27.7M. The largest sale was Western Alliance Bancorporation, an estimated $35M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q2 2022 buy was Perrigo: 684,450 shares worth $27.7M.
  • Segall Bryant & Hamill added most to Unilever in Q2 2022, an estimated $28M increase.
  • Segall Bryant & Hamill's biggest Q2 2022 reduction was Western Alliance Bancorporation, cutting an estimated $35M.
  • Segall Bryant & Hamill fully exited Anaplan, Inc. in Q2 2022, selling an estimated $22.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.88B portfolio in Q2 2022.
  • Segall Bryant & Hamill opened 20 new positions and closed 39 in Q2 2022.
  • Segall Bryant & Hamill's portfolio value fell 15% quarter-over-quarter to $8.88B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2022, filed 15 Aug 2022.